Cadrenal Therapeutics, Inc. (CVKD)
1.03
+0.03
(+3.00%)
USD |
NASDAQ |
Nov 06, 10:26
Cadrenal Therapeutics Net Income (Quarterly) : -3.323M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.323M |
| March 31, 2026 | -2.496M |
| December 31, 2025 | -3.039M |
| September 30, 2025 | -2.686M |
| June 30, 2025 | -3.667M |
| March 31, 2025 | -3.845M |
| December 31, 2024 | -4.187M |
| September 30, 2024 | -2.408M |
| June 30, 2024 | -2.393M |
| Date | Value |
|---|---|
| March 31, 2024 | -1.663M |
| December 31, 2023 | -1.144M |
| September 30, 2023 | -1.036M |
| June 30, 2023 | -1.003M |
| March 31, 2023 | -5.174M |
| December 31, 2022 | -5.009M |
| September 30, 2022 | -1.026M |
| June 30, 2022 | -0.5021M |
| March 31, 2022 | -0.1766M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 124.49M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 6.451B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.323M |
| EPS Diluted (Quarterly) | -1.140 |
| Enterprise Value | 0.7105M |
| Earnings Yield | -476.0% |
| Normalized Earnings Yield | -475.99 |